Comparison of the quantification of caffeine in human plasma by gas chromatography and ELISA

Brazilian Journal of Medical and Biological Research

Volumn 34, Issue 6, 2001, Pages 821-824

  Carregaro, A B ^a   Woods, W E ^b   Tobiri, T ^b   Queiroz Neto, A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Caffeine; ELISA; Gas chromatography; Plasma; Quantification

Indexed keywords

CAFFEINE;

ARTICLE; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GAS CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MEASUREMENT; PLASMA; QUANTITATIVE ASSAY;

EID: 0034953867     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2001000600019     Document Type: Article

References (14)

1. Graham DM (1978). Caffeine - Its identity, dietary sources, intake and biological effects. Nutrition Reviews, 36: 97-102.
2. Charmey DS, Heniger GR & Jatlow PI (1985). Increased anxiogenic effects of caffeine in panic disorders. Archives of General Psychiatry, 42: 233-243.
3. Myers MG (1988). Caffeine and cardiac arrhythmia. Chest, 94: 4-5.
4. Finney MJ, Karlsoon JA & Person CG (1985). Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation. British Journal of Pharmacology, 85: 29-36.
5. Gilman AG, Rall TW, Nies AS & Taylor P (1990). The Pharmacological Basis of Therapeutics. 8th edn. McGraw-Hill, Inc., New York.
6. Curatolo PW & Robertson D (1983). The health consequences of caffeine. Annals of Internal Medicine, 98: 641-653.
7. Greden JF (1981). Caffeinism and caffeine withdrawal. In: Lowinson JH & Ruiz P (Editors), Substance Abuse: Clinical Problems and Perspectives. Williams and Wilkins Co., Baltimore, 274-286.
8. Griffiths RR & Woodson PP (1988). Caffeine physical dependence: A review of human and laboratory animal studies. Psychopharmacology, 94: 437-451.
9. Salvadori MC, Velletri ME, Camargo MA & Araújo CP (1988). Identification of doping agents by chromatographic techniques and UV spectrophotometry. Analyst, 113: 1189-1195.
10. Edgar T, Tobin T, Tai HH, Schroedter D, Ice JT & Bass S (1996). ELISA assay for caffeine. Proceedings of the 11th International Conference of Racing Analysts and Veterinarians, Queensland, Australia, May 18-24, 478-480.
11. Greene EW, Woods WE & Tobin T (1983). Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horses. American Journal of Veterinary Research, 44: 57-63.
12. Hoel PG (1961). Elementary Statistics. 3rd edn. John Wiley & Sons, Inc., New York.
13. Shah VP, Midha KK, Digne S, McGilveray IJ, Skelly AY, Layloff T, Viswanathan CT, Cook CE, McDowall RD, Pittman KA & Spector S (1992). Analytical methods validation: Bioavailability, bioequivalence, and pharmacokinetic studies. Journal of Pharmaceutical Sciences, 81: 309-312
14. Tobin T, Watt DS, Kwiatkowski S, Tai HH & Blake JW (1988). Non-isotopic immunoassay drug tests in racing horses: A review of their application to pre-and post-race testing, drug quantification, and human drug testing. Research Communications in Chemical Pathology and Pharmacology, 62: 371-395.